US Patent 11352644 Compositions and methods for enhanced gene expression
Patent 11352644 was granted and assigned to Adverum Biotechnologies on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Annahita Keravala0
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Apr, 2023
Golden AI
Edits on 6 Apr, 2023
Golden AI
Infobox
Edits on 4 Apr, 2023
Golden AI
Infobox
Edits on 29 Mar, 2023
Golden AI
Infobox
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113526440
Date of Patent
June 7, 2022
0Patent Application Number
169985400
Date Filed
August 20, 2020
0Patent Citations
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Golden AI
Infobox
Edits on 22 Sep, 2022
Golden AI
Infobox
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+138 characters)
US Patent 11352644 Compositions and methods for enhanced gene expression
Article
The present disclosure provides polynucleotide cassettes, expression vectors, and methods for the expression of a gene in mammalian cells.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11352644
Date of patent
June 7, 2022
Patent application number
16998540
Date Filed
August 20, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11352644 Compositions and methods for enhanced gene expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.